Additionally, we retrieved protein expression data for SF3B6 from the UALCAN database, which indicated a significant increase in SF3B6 protein levels in liver cancer, glioblastoma, head and neck cancer, lung cancer, ovarian cancer, colon cancer, and breast cancer compared to normal tissues (Figure 1D). This evidence concerns the gene SF3B6 and breast cancer.